These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8882026)
1. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study. Beyeler C; Banks R; Thompson D; Forbes MA; Cooper EH; Bird HA J Rheumatol; 1996 Feb; 23(2):241-4. PubMed ID: 8882026 [TBL] [Abstract][Full Text] [Related]
2. Bone alkaline phosphatase in rheumatic diseases. Beyeler C; Banks RE; Thompson D; Forbes MA; Cooper EH; Bird H Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():379-84. PubMed ID: 7486797 [TBL] [Abstract][Full Text] [Related]
3. Osteocalcin in patients with rheumatoid arthritis. A one-year followup study. Franck H; Ittel TH; Tasch O; Herborn G; Rau R J Rheumatol; 1994 Jul; 21(7):1256-9. PubMed ID: 7966066 [TBL] [Abstract][Full Text] [Related]
4. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis. El Miedany YM; Abubakr IH; El Baddini M J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648 [TBL] [Abstract][Full Text] [Related]
6. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy. Rau R; Schleusser B; Herborn G; Karger T J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088 [TBL] [Abstract][Full Text] [Related]
7. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine. Capell HA; Maiden N; Madhok R; Hampson R; Thomson EA J Rheumatol; 1998 Oct; 25(10):1880-6. PubMed ID: 9779839 [TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials. Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127 [TBL] [Abstract][Full Text] [Related]
9. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen. Morote J; Lorente JA; Encabo G Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009 [TBL] [Abstract][Full Text] [Related]
10. Bone alkaline phosphatase in Paget's disease. Deftos LJ; Wolfert RL; Hill CS Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067 [TBL] [Abstract][Full Text] [Related]
11. The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis. Torikai E; Kageyama Y; Takahashi M; Suzuki M; Ichikawa T; Nagafusa T; Nagano A Rheumatology (Oxford); 2006 Jun; 45(6):761-4. PubMed ID: 16436492 [TBL] [Abstract][Full Text] [Related]
12. [Gamma-glutamyltranspeptidase in chronic polyarthritis. I. Comparison with a control group and relationship with alkaline phosphatase]. Rau R Z Rheumatol; 1977; 36(1-2):36-48. PubMed ID: 14455 [TBL] [Abstract][Full Text] [Related]
13. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs. Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314 [TBL] [Abstract][Full Text] [Related]
14. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T; Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo. Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356 [TBL] [Abstract][Full Text] [Related]
16. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739 [TBL] [Abstract][Full Text] [Related]
17. Alkaline phosphatase activity in the serum of patients with rheumatoid arthritis. Cimmino MA; Buffrini L; Barisone G; Bruzzone M; Accardo S Z Rheumatol; 1990; 49(3):143-6. PubMed ID: 2378172 [TBL] [Abstract][Full Text] [Related]
18. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats. DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950 [TBL] [Abstract][Full Text] [Related]
19. [Gamma-glutamyltranspeptidase in chronic polyarthritis. II. Influence of drugs]. Rau R Z Rheumatol; 1977; 36(1-2):49-59. PubMed ID: 14456 [TBL] [Abstract][Full Text] [Related]
20. Bone resorption and inflammatory inhibition efficacy of intermittent cyclical etidronate therapy in rheumatoid arthritis. Hasegawa J; Nagashima M; Yamamoto M; Nishijima T; Katsumata S; Yoshino S J Rheumatol; 2003 Mar; 30(3):474-9. PubMed ID: 12610804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]